HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kshipra Singh Selected Research

Cationic Amino Acid Transporter 2

8/2013Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response.
1/2011Cationic amino acid transporter 2 enhances innate immunity during Helicobacter pylori infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kshipra Singh Research Topics

Disease

14Colitis
01/2022 - 03/2010
9Inflammation (Inflammations)
01/2022 - 01/2012
7Carcinogenesis
01/2022 - 01/2013
6Ulcerative Colitis
01/2022 - 01/2013
6Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2021 - 06/2008
6Infections
01/2019 - 01/2011
5Neoplasms (Cancer)
11/2021 - 03/2015
3Gastritis
01/2021 - 11/2010
2Body Weight (Weight, Body)
01/2018 - 01/2012
2Leukemia
09/2014 - 10/2011
2Sepsis (Septicemia)
02/2011 - 06/2008
2Neuroinflammatory Diseases
02/2011 - 06/2008
1Dysbiosis
01/2022
1Carcinoma (Carcinomatosis)
01/2021
1Metaplasia
01/2021
1Wounds and Injuries (Trauma)
01/2019
1Colonic Neoplasms (Colon Cancer)
01/2018
1Bacterial Infections (Bacterial Infection)
01/2017
1Weight Loss (Weight Reduction)
01/2013
1Breast Neoplasms (Breast Cancer)
01/2011
1Neoplasm Metastasis (Metastasis)
01/2011
1Malaria
12/2007

Drug/Important Bio-Agent (IBA)

11Dextran SulfateIBA
01/2022 - 02/2011
7Arginine (L-Arginine)FDA Link
01/2019 - 01/2011
6AzoxymethaneIBA
01/2022 - 01/2013
5Messenger RNA (mRNA)IBA
01/2022 - 01/2011
4PolyaminesIBA
01/2022 - 02/2011
4Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2010
4CytokinesIBA
01/2019 - 02/2011
3Interleukin-17 (Interleukin 17)IBA
01/2018 - 02/2011
3Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
01/2018 - 02/2011
2Polyamine OxidaseIBA
01/2022 - 01/2018
2SpermidineIBA
01/2022 - 01/2018
2ChemokinesIBA
01/2019 - 01/2018
2EnzymesIBA
01/2018 - 02/2011
2AntigensIBA
09/2014 - 10/2011
2Dextrans (Dextran)FDA Link
10/2013 - 01/2013
2Amino AcidsFDA Link
08/2013 - 05/2012
2Cationic Amino Acid Transporter 2IBA
08/2013 - 01/2011
2ApolipoproteinsIBA
02/2011 - 06/2008
2Peptides (Polypeptides)IBA
02/2011 - 06/2008
2Apolipoproteins E (ApoE)IBA
02/2011 - 06/2008
1DefensinsIBA
01/2022
1AntibodiesIBA
11/2021
1DNA AdductsIBA
01/2021
1Insulin (Novolin)FDA Link
01/2021
1isolevuglandinIBA
01/2021
1GastrinsIBA
01/2021
1Granzymes (Granzyme)IBA
01/2021
1Essential Amino AcidsIBA
01/2019
1Interleukin-4 (Interleukin 4)IBA
01/2019
1Interleukin-3 (Interleukin 3)IBA
01/2019
1Histones (Histone)IBA
01/2018
1ChromatinIBA
01/2018
1Lysine (L-Lysine)FDA Link
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1EuchromatinIBA
01/2017
1Co-Repressor ProteinsIBA
03/2015
1Interleukin-2 Receptors (IL 2 Receptor)IBA
09/2014
1Interleukin-15 (Interleukin 15)IBA
09/2014
1SodiumIBA
10/2013
1Epidermal Growth Factor (EGF)IBA
01/2013
1SeleniumIBA
01/2013
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2013
1OxazoloneIBA
01/2013
1Chemokine CCL11IBA
01/2013
1Nitric Oxide Synthase (NO Synthase)IBA
01/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012
1Peroxidase (Myeloperoxidase)IBA
01/2012
1Histocompatibility Antigens Class IIBA
10/2011
1NF-kappa B (NF-kB)IBA
02/2011
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2011
1CyclinsIBA
01/2011
1Cyclin D1IBA
01/2011
1afimoxifene (hydroxytamoxifen)IBA
01/2011
1Estrogens (Estrogen)FDA Link
01/2011
1Eflornithine (Ornidyl)FDA Link
11/2010
1Basic Amino Acid Transport SystemsIBA
11/2010
1ArginaseIBA
03/2010
1Phenobarbital (Luminal)FDA Link
06/2008
1Antimalarials (Antimalarial Agents)IBA
12/2007
1VaccinesIBA
12/2007

Therapy/Procedure

3Chemoprevention
11/2021 - 01/2018
1Complementary Therapies (Alternative Medicine)
01/2019
1Therapeutics
01/2013
1Intraperitoneal Injections
02/2011